Cayuga Biotech
Developer of biomimetic therapeutic agents designed for hemorrhage control. The company's platform harnesses the body's innate clotting mechanisms using a synthetic short chain polyphosphate silica na...
Valuation
$0
Share Price
N/A
Total Raised
$9.5M
Last Round
N/A